We are live on ! Find out more
LJHT

Laurie J. Hall Trustee Portfolio holdings

AUM $322M
1-Year Est. Return 33.73%
This Fund
S&P 500
This Quarter Est. Return
+3.38%
1 Year Est. Return
+33.73%
3 Year Est. Return
+96.04%
5 Year Est. Return
+120.73%
10 Year Est. Return
AUM
$193M
AUM Growth
+$2.77M
Cap. Flow
-$1.09M
Cap. Flow %
-0.56%
Top 10 Hldgs %
35.31%
Holding
340
New
3
Increased
28
Reduced
67
Closed
8

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$1.07M
2
DD icon
DuPont de Nemours
DD
+$807K
3
XYL icon
Xylem
XYL
+$702K
4
NYT icon
New York Times
NYT
+$670K
5
ROK icon
Rockwell Automation
ROK
+$554K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.2M
2
XLNX
Xilinx Inc
XLNX
+$481K
3
MSFT icon
Microsoft
MSFT
+$420K
4
PEP icon
PepsiCo
PEP
+$373K
5
SYK icon
Stryker
SYK
+$282K

Sector Composition

Rank Sector Weight
1 Healthcare 25.24%
2 Technology 19.8%
3 Industrials 10.75%
4 Consumer Staples 9.98%
5 Financials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEA icon
26
Vanguard FTSE Developed Markets ETF
VEA
$229B
$2.21M 1.15%
53,075
AMAT icon
27
Applied Materials
AMAT
$409B
$2.17M 1.13%
48,327
XYL icon
28
Xylem
XYL
$27.5B
$2.07M 1.08%
24,790
+8,815
+55% +$702K
NKE icon
29
Nike
NKE
$61.8B
$2.04M 1.06%
24,258
-2,017
-8% -$170K
ROK icon
30
Rockwell Automation
ROK
$53.5B
$2.03M 1.05%
12,400
+3,280
+36% +$554K
NVS icon
31
Novartis
NVS
$297B
$1.99M 1.03%
21,800
-2,696
-11% -$228K
ABBV icon
32
AbbVie
ABBV
$446B
$1.97M 1.02%
27,086
-15,221
-36% -$1.2M
APD icon
33
Air Products & Chemicals
APD
$65.7B
$1.95M 1.01%
8,625
-300
-3% -$62.1K
UL icon
34
Unilever
UL
$137B
$1.95M 1.01%
27,938
AMGN icon
35
Amgen
AMGN
$208B
$1.72M 0.89%
9,350
STT icon
36
State Street
STT
$50.7B
$1.68M 0.87%
29,938
-400
-1% -$24.9K
AMZN icon
37
Amazon
AMZN
$2.93T
$1.66M 0.86%
17,520
-2,660
-13% -$248K
PFE icon
38
Pfizer
PFE
$143B
$1.54M 0.8%
37,392
EMR icon
39
Emerson Electric
EMR
$84.2B
$1.43M 0.74%
21,432
-400
-2% -$26.8K
PYPL icon
40
PayPal
PYPL
$49B
$1.4M 0.73%
12,240
+1,341
+12% +$149K
BDX icon
41
Becton Dickinson
BDX
$45.6B
$1.38M 0.72%
5,630
+4,617
+456% +$1.07M
WBA
42
DELISTED
Walgreens Boots Alliance
WBA
$1.35M 0.7%
24,794
-1,001
-4% -$53.2K
CVX icon
43
Chevron
CVX
$393B
$1.29M 0.67%
10,407
-148
-1% -$17.9K
GOOGL icon
44
Alphabet (Google) Class A
GOOGL
$4.35T
$1.29M 0.67%
23,740
-500
-2% -$28.9K
CNI icon
45
Canadian National Railway
CNI
$76.8B
$1.25M 0.65%
13,525
+400
+3% +$36.7K
BRK.B icon
46
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.22M 0.63%
5,740
CHTR icon
47
Charter Communications
CHTR
$17.4B
$1.22M 0.63%
3,086
SPY icon
48
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$1.22M 0.63%
4,155
-160
-4% -$46.1K
VXUS icon
49
Vanguard Total International Stock ETF
VXUS
$155B
$1.2M 0.62%
22,675
TJX icon
50
TJX Companies
TJX
$174B
$1.17M 0.61%
22,165
-560
-2% -$29.8K

Similar funds

Laurie J. Hall Trustee's Q2 2019 Portfolio in Review

As of Q2 2019, Laurie J. Hall Trustee held 340 positions worth $193M, up 1.5% from $190M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 3.2%. Laurie J. Hall Trustee opened 3 new positions and exited 8, leaving the 340-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Laurie J. Hall Trustee's largest Q2 2019 buy was Dow Inc: 4,858 shares worth $240K.
  • Laurie J. Hall Trustee added most to Becton Dickinson in Q2 2019, an estimated $1.07M increase.
  • Laurie J. Hall Trustee's biggest Q2 2019 reduction was AbbVie, cutting an estimated $1.2M.
  • Laurie J. Hall Trustee fully exited iShares Core S&P Mid-Cap ETF in Q2 2019, selling an estimated $34K.
  • Laurie J. Hall Trustee's ten largest holdings make up 35% of its $193M portfolio in Q2 2019.
  • Laurie J. Hall Trustee opened 3 new positions and closed 8 in Q2 2019.
  • Laurie J. Hall Trustee's portfolio value rose 1.5% quarter-over-quarter to $193M.

Based on Laurie J. Hall Trustee's 13F filing for Q2 2019, filed 1 Aug 2019.